📣 VC round data is live. Check it out!

Ezaki Glico Co Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ezaki Glico Co and similar public comparables like Tate & Lyle, Universal Robina, Cisarua Mountain Dairy, Yankershop Food Co and more.

Ezaki Glico Co Overview

About Ezaki Glico Co

Ezaki Glico Co Ltd is a Japanese food company. The reportable segments of the company are Health and Food Business includes the production and sales of health-related products, retort-packed food and others; Dairy Food Business includes the production and sales of dairy products, western-style fresh confectioneries, ice cream and others; Nutritional Confectionery Business includes the production and sales of chocolate, cookies and others; Food Ingredients Business: includes the production and sales of wheat protein, starch, food colouring and others; Other Domestic Business includes directly managed stores business, Office Glico business and others and Overseas Business includes the production and sales of chocolate, cookies and others overseas.


Founded

1929

HQ

Japan

Employees

9.0K

Website

glico.com

Financials (LTM)

Revenue: $2B
EBITDA: $194M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ezaki Glico Co Financials

Ezaki Glico Co reported last 12-month revenue of $2B and EBITDA of $194M.

In the same LTM period, Ezaki Glico Co generated $961M in gross profit, $194M in EBITDA, and $44M in net income.


Ezaki Glico Co P&L

In the most recent fiscal year, Ezaki Glico Co reported revenue of $2B and EBITDA of $185M.

Ezaki Glico Co is profitable as of last fiscal year, with gross margin of 37%, EBITDA margin of 8%, and net margin of 1%.

See analyst estimates for Ezaki Glico Co
LTMLast FY202320242025202620272028
Revenue$2B$2B$2B$2B$2B
Gross Profit$961M$863M$791M$815M$863M
Gross Margin40%37%37%39%37%
EBITDA$194M$185M$217M$185M$178M
EBITDA Margin8%8%10%9%8%
EBIT Margin3%2%6%3%2%
Net Profit$44M$33M$90M$52M$32M
Net Margin2%1%4%2%1%

Financial data powered by Morningstar, Inc.

Ezaki Glico Co Stock Performance

Ezaki Glico Co has current market cap of $2B, and enterprise value of $2B.


Ezaki Glico Co's stock price is $35.18.

Ezaki Glico Co has an EPS (earnings per share) of $0.52.

See more trading valuation data for Ezaki Glico Co
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B0.1%———$0.52

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ezaki Glico Co Valuation Multiples

Ezaki Glico Co trades at 0.8x EV/Revenue multiple, and 9.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Ezaki Glico Co

Ezaki Glico Co Financial Valuation Multiples

As of May 10, 2026, Ezaki Glico Co has market cap of $2B and EV of $2B.

Ezaki Glico Co has a P/E ratio of 50.5x.

LTMLast FY202320242025202620272028
EV/Revenue0.8x0.8x0.9x0.9x0.8x
EV/EBITDA9.7x10.1x8.6x10.1x10.5x
EV/EBIT27.8x32.9x15.7x26.5x33.5x
EV/Gross Profit1.9x2.2x2.4x2.3x2.2x
P/E50.5x67.7x24.6x42.9x69.1x
EV/FCF16.6x15.3x30.3x(18.7x)19.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ezaki Glico Co Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ezaki Glico Co Margins & Growth Rates

Ezaki Glico Co grew revenue by 3% and EBITDA by 14% in the last fiscal year.

In the most recent fiscal year, Ezaki Glico Co reported gross margin of 37%, EBITDA margin of 8%, and net margin of 1%.

See estimated margins and future growth rates for Ezaki Glico Co

Ezaki Glico Co Margins

Last FY202420252026202720282029
Gross Margin37%39%37%36%
EBITDA Margin8%9%8%9%
EBIT Margin2%3%2%4%
Net Margin1%2%1%3%
FCF Margin5%(5%)4%4%

Ezaki Glico Co Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%(0%)9%5%
Gross Profit Growth1%3%6%1%
EBITDA Growth14%(15%)(4%)18%
EBIT Growth51%(41%)(21%)54%
Net Profit Growth95%(43%)(38%)100%
FCF Growth(22%)(262%)(195%)0%

Data powered by FactSet, Inc. and Morningstar, Inc.

Ezaki Glico Co Operational KPIs

Ezaki Glico Co's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Ezaki Glico Co's Rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ezaki Glico Co's Rule of X is 22% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Ezaki Glico Co
LTMLast FY202320242025202620272028
Rule of 4011%14%———
Bessemer Rule of X15%22%———
Revenue per Employee—$0.3M———
Opex per Employee—$0.1M———
S&M Expenses to Revenue—8%7%8%8%
G&A Expenses to Revenue—8%8%8%8%
Opex to Revenue—34%32%35%35%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ezaki Glico Co Competitors

Ezaki Glico Co competitors include Tate & Lyle, Universal Robina, Cisarua Mountain Dairy, Yankershop Food Co, Monde Nissin, Mayora Indah, Premier Foods, Chagee, AVI and Savola Group.

Most Ezaki Glico Co public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Tate & Lyle1.5x1.3x6.9x6.3x
Universal Robina0.8x—6.8x—
Cisarua Mountain Dairy3.2x3.1x13.7x13.4x
Yankershop Food Co2.8x2.7x14.6x13.8x
Monde Nissin1.3x—7.8x—
Mayora Indah1.1x1.1x8.8x8.4x
Premier Foods1.7x1.6x8.4x8.6x
Chagee0.5x0.5x4.1x3.6x

This data is available for Pro users. Sign up to see all Ezaki Glico Co competitors and their valuation data.

Start Free Trial

Ezaki Glico Co Investment Activity

Ezaki Glico Co has invested in 2 companies to date.

Latest investment by Ezaki Glico Co was on October 11th 2022. Ezaki Glico Co invested in Viome in their $67M Series C round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Ezaki Glico Co

Viome
Viome
FiNC Technologies
Description
Viome is a Bellevue-headquartered precision health company analyzing microbiome, mitochondrial, and cellular data through at-home test kits. Established in 2016, it provides personalized nutrition and lifestyle recommendations based on RNA sequencing of gut, oral, and cellular samples. The platform tracks biological age and health metrics for users seeking optimized wellness plans.
Viome is a Bellevue-headquartered precision health company analyzing microbiome, mitochondrial, and cellular data through at-home test kits. Established in 2016, it provides personalized nutrition and lifestyle recommendations based on RNA sequencing of gut, oral, and cellular samples. The platform tracks biological age and health metrics for users seeking optimized wellness plans.
FiNC Technologies is a Tokyo-based health technology firm that develops the FiNC app for wellness management. The platform integrates AI-powered personalized coaching, activity tracking, meal logging, and social challenges to help users monitor weight, steps, sleep, and nutrition. Partnerships with insurers like Sony Life provide premium features, while machine learning algorithms deliver tailored health insights to millions of Japanese users.
HQ CountryUnited StatesUnited StatesJapan
HQ City
Seattle, WA
Seattle, WA
Nishikicho
Deal Date11 Oct 202210 Nov 202120 Sep 2018
RoundSeries CSeries CSeries D
Raised$67M$54M$49M
InvestorsBetter Health Group; Bold Capital Partners; Ezaki Glico; Khosla Ventures; Ocgrow Ventures; WestRiver GroupBetter Health Group; Bold Capital Partners; Ezaki Glico; Khosla Ventures; Ocgrow Ventures; WestRiver GroupArtra Group; Chubu Electric Power; Dai-ichi Life; Ezaki Glico; Hiroshima Venture Capital; J-WAVE; Kodansha; Mizuho Securities; NEC; Rohto Pharmaceutical; SBI Investment; Shiseido
Valuation$339Mundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Ezaki Glico Co investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ezaki Glico Co

When was Ezaki Glico Co founded?Ezaki Glico Co was founded in 1929.
Where is Ezaki Glico Co headquartered?Ezaki Glico Co is headquartered in Japan.
How many employees does Ezaki Glico Co have?As of today, Ezaki Glico Co has over 9K employees.
Is Ezaki Glico Co publicly listed?Yes, Ezaki Glico Co is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Ezaki Glico Co?Ezaki Glico Co trades under 2206 ticker.
When did Ezaki Glico Co go public?Ezaki Glico Co went public in 1961.
Who are competitors of Ezaki Glico Co?Ezaki Glico Co main competitors include Tate & Lyle, Universal Robina, Cisarua Mountain Dairy, Yankershop Food Co, Monde Nissin, Mayora Indah, Premier Foods, Chagee, AVI, Savola Group.
What is the current market cap of Ezaki Glico Co?Ezaki Glico Co's current market cap is $2B.
What is the current revenue of Ezaki Glico Co?Ezaki Glico Co's last 12 months revenue is $2B.
What is the current revenue growth of Ezaki Glico Co?Ezaki Glico Co revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Ezaki Glico Co?Current revenue multiple of Ezaki Glico Co is 0.8x.
Is Ezaki Glico Co profitable?Yes, Ezaki Glico Co is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Ezaki Glico Co?Ezaki Glico Co's last 12 months EBITDA is $194M.
What is Ezaki Glico Co's EBITDA margin?Ezaki Glico Co's last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of Ezaki Glico Co?Current EBITDA multiple of Ezaki Glico Co is 9.7x.
What is the current FCF of Ezaki Glico Co?Ezaki Glico Co's last 12 months FCF is $113M.
What is Ezaki Glico Co's FCF margin?Ezaki Glico Co's last 12 months FCF margin is 5%.
What is the current EV/FCF multiple of Ezaki Glico Co?Current FCF multiple of Ezaki Glico Co is 16.6x.
How many companies Ezaki Glico Co has acquired to date?Ezaki Glico Co hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Ezaki Glico Co has invested to date?As of May 2026, Ezaki Glico Co has invested in 2 companies.
What was the last Ezaki Glico Co investment?On 11th October 2022 Ezaki Glico Co invested in Viome, participating in a $67M Series C round at $339M valuation, alongside Better Health Group, Bold Capital Partners, Ezaki Glico, Khosla Ventures, Ocgrow Ventures, and WestRiver Group.
In what companies Ezaki Glico Co invested in?Ezaki Glico Co invested in Viome and FiNC Technologies.

See public comps similar to Ezaki Glico Co

Lists including Ezaki Glico Co

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial